OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice
Grant C. Glatfelter, John S. Partilla, Michael H. Baumann
Neuropsychopharmacology (2021) Vol. 47, Iss. 4, pp. 924-932
Open Access | Times Cited: 16
Grant C. Glatfelter, John S. Partilla, Michael H. Baumann
Neuropsychopharmacology (2021) Vol. 47, Iss. 4, pp. 924-932
Open Access | Times Cited: 16
Showing 16 citing articles:
Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1181-1196
Open Access | Times Cited: 56
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1181-1196
Open Access | Times Cited: 56
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 17
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 17
Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice
Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 567-577
Closed Access | Times Cited: 12
Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 567-577
Closed Access | Times Cited: 12
Pharmaco-toxicological effects of the synthetic cannabinoids 4F-ABUTINACA, SDB-005, and JWH-018 in mice. In vitro and in vivo studies
Xuwen Luo, Lixin Kuai, Xuesong Shi, et al.
European Journal of Pharmacology (2025), pp. 177586-177586
Closed Access
Xuwen Luo, Lixin Kuai, Xuesong Shi, et al.
European Journal of Pharmacology (2025), pp. 177586-177586
Closed Access
Noncovalent Interaction-Based Probe Design for PET-Facilitated Fluorescence Sensing of Synthetic Cannabinoids
Jiahao Dong, Chuanfang Zhao, Jinliang Ning, et al.
ACS Omega (2025)
Open Access
Jiahao Dong, Chuanfang Zhao, Jinliang Ning, et al.
ACS Omega (2025)
Open Access
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 641-653
Open Access | Times Cited: 3
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 641-653
Open Access | Times Cited: 3
In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists
Julie A. Marusich, Thomas F. Gamage, Yanan Zhang, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173467-173467
Open Access | Times Cited: 15
Julie A. Marusich, Thomas F. Gamage, Yanan Zhang, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173467-173467
Open Access | Times Cited: 15
Differential cannabinoid‐like effects and pharmacokinetics of ADB‐BICA, ADB‐BINACA, ADB‐4en‐PINACA and MDMB‐4en‐PINACA in mice: A comparative study
Fenghua Zhou, Xiaoli Wang, Sujun Tan, et al.
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 2
Fenghua Zhou, Xiaoli Wang, Sujun Tan, et al.
Addiction Biology (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 2
Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues
Jack Markham, Eric Sparkes, Rochelle Boyd, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 8, pp. 1281-1295
Closed Access | Times Cited: 9
Jack Markham, Eric Sparkes, Rochelle Boyd, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 8, pp. 1281-1295
Closed Access | Times Cited: 9
Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 21, pp. 3928-3940
Open Access | Times Cited: 5
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 21, pp. 3928-3940
Open Access | Times Cited: 5
Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites
Liesl K. Janssens, Simon Hudson, David M. Wood, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 11, pp. 2935-2945
Closed Access | Times Cited: 5
Liesl K. Janssens, Simon Hudson, David M. Wood, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 11, pp. 2935-2945
Closed Access | Times Cited: 5
Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA
Ruijia Chen, Zi‐hua Zhang, Shenglan Yang, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 12, pp. 1578-1592
Closed Access
Ruijia Chen, Zi‐hua Zhang, Shenglan Yang, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 12, pp. 1578-1592
Closed Access
Understanding receptor efficacy and biases: bioluminescence resonance energy transfer analysis of dimethylindane head group and cumyl analogs of synthetic cannabinoid receptor agonists
Soibifaa Michelle Briggs
(2024)
Open Access
Soibifaa Michelle Briggs
(2024)
Open Access
Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice
Marthe M. Vandeputte, Grant C. Glatfelter, Donna Walther, et al.
Pharmacological Research (2024) Vol. 210, pp. 107503-107503
Open Access
Marthe M. Vandeputte, Grant C. Glatfelter, Donna Walther, et al.
Pharmacological Research (2024) Vol. 210, pp. 107503-107503
Open Access
Unveiling the toxicity of JWH-018 and JWH-019: Insights from behavioral and molecular studies in vivo and vitro
Fenghua Zhou, Yan Shi, Sujun Tan, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 289, pp. 117500-117500
Open Access
Fenghua Zhou, Yan Shi, Sujun Tan, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 289, pp. 117500-117500
Open Access
A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
